Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Kirstin Nelson

Diagnostic Radiology Savannah, GA Medical Doctor

NPI 1104858307 CMS profile 140401

4750 Waters Ave, Suite 500, Savannah, GA 31404

Open in the dashboard

General payments

$7,487

262 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Kirstin Nelson of Savannah, GA is reported in the CMS Open Payments database as having received $7,487 across 262 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 92nd percentile of Diagnostic Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,416 51
2024 General $1,327 56
2023 General $605 31
2022 General $993 23
2021 General $979 29
2020 General $1,090 40
2019 General $1,078 32

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Kirstin Nelson
  • Diagnostic Radiology median
  • Middle half of Diagnostic Radiology
  • National median

In program year 2025, general payments to Kirstin Nelson were reported at $1,416. Among 8,325 Diagnostic Radiology profiles paid that year, the median was $112 and the middle half received between $32 and $349.

Show as a table
Year Kirstin Nelson Diagnostic Radiology median Middle half National median
2019 $1,078 $108 $29–$318 $163
2020 $1,090 $65 $21–$252 $114
2021 $979 $92 $24–$292 $132
2022 $993 $104 $29–$294 $149
2023 $605 $110 $29–$337 $160
2024 $1,327 $113 $30–$356 $164
2025 $1,416 $112 $32–$349 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Boston Scientific Corporation $1,031 43 payments
  2. Inari Medical, Inc. $994 52 payments
  3. W. L. Gore & Associates, Inc. $921 15 payments
  4. AngioDynamics, Inc. $836 36 payments
  5. Stryker Corporation $656 27 payments
  6. Endologix, Inc. $600 6 payments
  7. Medtronic Vascular, Inc. $438 14 payments
  8. Medtronic, Inc. $267 6 payments
  9. Shockwave Medical, Inc $208 9 payments
  10. Philips Electronics North America Corporation $204 4 payments
  11. Other $1,332 50 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $7,464 261 payments
  2. Travel and Lodging $23 1 payment
Products named General payments · program years 2019–2025
  1. CT THROMBECTOMY SYSTEM KIT $1,062 55 payments
  2. FLOWTRIEVER CATHETER, S $1,062 55 payments
  3. AURYON LASER SYSTEM 100-120 VAC $768 33 payments
  4. VIABAHN VBX Balloon Expandable Endoprosthesis $470 6 payments
  5. ARTIX MT $392 15 payments
  6. AFX2 Bifurcated Endograft System $314 3 payments
  7. Ovation iX Iliac Stent Graft $314 3 payments
  8. GORE VIABAHN VBX Balloon Expandable Endo $224 2 payments
  9. Alto Abdominal Stent Graft System $223 2 payments
  10. GENERAL VASCULAR INTERVENTION $187 4 payments
  11. Other $3,725 141 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 2 drugs

Part D claims

22

Median for Interventional Radiology: 38

Drug cost

$8,145

Median for Interventional Radiology: $333

Branded share of claims

50%

Median for Interventional Radiology: 53%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 11 $8,132
Prednisone Generic 11 $13

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 554 Part D prescribers listed as Interventional Radiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 78 billing codes

Paid by Medicare

$125,647

Of which drugs: $606

Medicare patients

152

Average age 71

Services billed

2,624

77 women, 75 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Chronic kidney disease 67%
Diabetes 62%
Heart failure 48%
Arthritis 44%
Ischemic heart disease 40%
COPD 31%
Depression 29%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml Q9966 Office 35 1,927 $561
Injection, fentanyl citrate, 0.1 mg J3010 Office 30 35 $25
Injection, midazolam hydrochloride, per 1 mg J2250 Office 30 53 $6

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

262 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Diagnostic Radiology in Georgia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record